Literature DB >> 33941144

Cell spheroids are as effective as single cells suspensions in the treatment of critical-sized bone defects.

Lisa Findeisen1,2, Julia Bolte3,4, Corina Vater3,4, Cathleen Petzold3,4, Mandy Quade4, Lars Müller3,4, Stuart B Goodman5, Stefan Zwingenberger3,4.   

Abstract

BACKGROUND: Due to their multilineage potential and high proliferation rate, mesenchymal stem cells (MSC) indicate a sufficient alternative in regenerative medicine. In comparison to the commonly used 2-dimensional culturing method, culturing cells as spheroids stimulates the cell-cell communication and mimics the in vivo milieu more accurately, resulting in an enhanced regenerative potential. To investigate the osteoregenerative potential of MSC spheroids in comparison to MSC suspensions, cell-loaded fibrin gels were implanted into murine critical-sized femoral bone defects.
METHODS: After harvesting MSCs from 4 healthy human donors and preculturing and immobilizing them in fibrin gel, cells were implanted into 2 mm murine femoral defects and stabilized with an external fixator. Therefore, 26 14- to 15-week-old nu/nu NOD/SCID nude mice were randomized into 2 groups (MSC spheroids, MSC suspensions) and observed for 6 weeks. Subsequently, micro-computed tomography scans were performed to analyze regenerated bone volume and bone mineral density. Additionally, histological analysis, evaluating the number of osteoblasts, osteoclasts and vessels at the defect side, were performed. Statistical analyzation was performed by using the Student's t-test and, the Mann-Whitney test. The level of significance was set at p = 0.05.
RESULTS: μCT-analysis revealed a significantly higher bone mineral density of the MSC spheroid group compared to the MSC suspension group. However, regenerated bone volume of the defect side was comparable between both groups. Furthermore, no significant differences in histological analysis between both groups could be shown.
CONCLUSION: Our in vivo results reveal that the osteo-regenerative potential of MSC spheroids is similar to MSC suspensions.

Entities:  

Keywords:  Bone regeneration; Cell spheroids; Critical-sized bone defect; Mesenchymal stromal cells

Year:  2021        PMID: 33941144     DOI: 10.1186/s12891-021-04264-y

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  41 in total

1.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

Review 2.  Bone cells and matrices in orthopedic tissue engineering.

Authors:  J E Fleming; C N Cornell; G F Muschler
Journal:  Orthop Clin North Am       Date:  2000-07       Impact factor: 2.472

3.  Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies.

Authors:  M Zhang; D Methot; V Poppa; Y Fujio; K Walsh; C E Murry
Journal:  J Mol Cell Cardiol       Date:  2001-05       Impact factor: 5.000

Review 4.  Bone graft substitutes.

Authors:  Cato Laurencin; Yusuf Khan; Saadiq F El-Amin
Journal:  Expert Rev Med Devices       Date:  2006-01       Impact factor: 3.166

5.  Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.

Authors:  S P Bruder; N Jaiswal; S E Haynesworth
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

6.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

Review 7.  Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis.

Authors:  Annelies Bronckaers; Petra Hilkens; Wendy Martens; Pascal Gervois; Jessica Ratajczak; Tom Struys; Ivo Lambrichts
Journal:  Pharmacol Ther       Date:  2014-03-01       Impact factor: 12.310

8.  Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo.

Authors:  A J Friedenstein; R K Chailakhyan; N V Latsinik; A F Panasyuk; I V Keiliss-Borok
Journal:  Transplantation       Date:  1974-04       Impact factor: 4.939

9.  Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

Authors:  C Campagnoli; I A Roberts; S Kumar; P R Bennett; I Bellantuono; N M Fisk
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

Review 10.  Recent progress in bone induction by osteogenin and bone morphogenetic proteins: challenges for biomechanical and tissue engineering.

Authors:  A H Reddi; N S Cunningham
Journal:  J Biomech Eng       Date:  1991-05       Impact factor: 2.097

View more
  3 in total

1.  Bone regeneration in rat calvarial defects using dissociated or spheroid mesenchymal stromal cells in scaffold-hydrogel constructs.

Authors:  Siddharth Shanbhag; Salwa Suliman; Samih Mohamed-Ahmed; Carina Kampleitner; Mohamed Nageeb Hassan; Patrick Heimel; Toni Dobsak; Stefan Tangl; Anne Isine Bolstad; Kamal Mustafa
Journal:  Stem Cell Res Ther       Date:  2021-11-14       Impact factor: 6.832

2.  Ectopic Bone Tissue Engineering in Mice Using Human Gingiva or Bone Marrow-Derived Stromal/Progenitor Cells in Scaffold-Hydrogel Constructs.

Authors:  Siddharth Shanbhag; Carina Kampleitner; Samih Mohamed-Ahmed; Mohammed Ahmad Yassin; Harsh Dongre; Daniela Elena Costea; Stefan Tangl; Andreas Stavropoulos; Anne Isine Bolstad; Salwa Suliman; Kamal Mustafa
Journal:  Front Bioeng Biotechnol       Date:  2021-11-30

3.  The Effects of Transforming Growth Factor-β1 on the Differentiation of Cell Organoids Composed of Gingiva-Derived Stem Cells.

Authors:  Young-Min Song; Kyung-Hwan Na; Hyun-Jin Lee; Jun-Beom Park
Journal:  Biomed Res Int       Date:  2022-07-14       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.